Immediate Impact
61 standout
Citing Papers
Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
2025 Standout
Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
Works of Katarína Mitrová being referenced
Safety of Ustekinumab and Vedolizumab During Pregnancy—Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study
2022
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Katarína Mitrová | 240 | 163 | 49 | 180 | 46 | 521 | |
| E. Graham Davies | 218 | 114 | 96 | 103 | 31 | 592 | |
| Serap Aksoylar | 106 | 78 | 103 | 114 | 47 | 572 | |
| Jaime Inostroza | 161 | 66 | 130 | 73 | 42 | 559 | |
| Jason M. Shapiro | 81 | 218 | 118 | 54 | 33 | 493 | |
| G.G. Crane | 85 | 67 | 43 | 251 | 32 | 534 | |
| Dan Năvolan | 102 | 41 | 152 | 64 | 70 | 643 | |
| Mahmut Çarin | 237 | 48 | 115 | 149 | 45 | 642 | |
| Sunday Pam | 126 | 27 | 86 | 100 | 40 | 531 | |
| Peter R. McConnachie | 310 | 65 | 54 | 66 | 36 | 582 | |
| Jonathan Nolan | 195 | 104 | 83 | 236 | 20 | 592 |
All Works
Login with ORCID to disown or claim papers
Loading papers...